Stable disease, diagnosis and dose are prognostic factors for survival after interleukin-2 immunotherapy
========================================================================================================

* Nathan H Kwan
* Brittany A Ockenfels
* Charmi Patel
* Gerald P Miletello
* Paula R Brantley